An observational study in Conscripts, Military Induction Board and ENT Disease, sponsored by Medical University of Graz. Not yet recruiting. Open to male participants aged 17 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-27.
Sponsored by Medical University of Graz · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of the present study will be to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.
Therefore, questionnaires and data of medical examinations, aquired routinely at the military induction board, will be analysed.
Rhinosinusitis is a very common complaint at ENT departments, whereby symptoms of the underlying disease are varying. Therefore, there is growing interest in prevalence of rhinosinusitis including differences in prevalence's depending on where the patient grew up. Further, there is growing interest in answering the question if different factors, including ENT-surgeries in medical history have an impact on symptoms of rhinosinusitis.
Within the past few years there is growing interest in carring out as many HPV-vaccinations as possible in order to reduce the prevalence of HPV-associated cancers.
Further, in adolescents there is a growing number of hearing impairments, including hearing loss and/or sounds in the ears.
Next, since the beginning of the COVID pandemic there are very common complaints in adult and pediatric patients about persistent medical problems for weeks or months after an acute SARS-CoV-2-infection and cannot be explained by another diagnosis, called long- Covid disease.
The military induction board of conscripts enables access to data from a cross-section of the population, with common characteristics of gender and age.
In the present study we want therefore to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.
251 studies on the registry are indexed under Rhinosinusitis; 69 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 120 across 61 observational studies indexed under Rhinosinusitis.
Browse Rhinosinusitis studies →Medical University of Graz is the lead sponsor of 471 studies on the registry; 98 are open to participants now.
Compared within Rhinosinusitis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Otorhinolaryngologic Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
All male Austrian conscripts who take part at the military inductions board are eligible for the study inclusion.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Prevalence of rhinosinusitis
To assess whether there is a difference in prevalence of rhinosinusitis in urban-bred conscripts compared to non-urban-bred conscripts.
Time frame: Through data collection, an average of 1 week
Prevalence of human papilloma virus vaccination
To assess whether there is a difference in prevalence of human papilloma virus vaccinations in urban-bred conscripts compared to non-urban-bred conscripts.
Time frame: Through data collection, an average of 1 week
Prevalence of hearing impairment
To assess whether there is a difference in prevalence of hearing impairment in urban-bred conscripts compared to non-urban-bred conscripts.
Time frame: Through data collection, an average of 1 week
Prevalence of long-COVID disease
To assess whether there is a difference in prevalence of long-COVID disease in vaccinated conscripts compared to no-vaccinated conscripts.
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess prevalence of rhinosinusitis in conscripts at the military induction board
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess the different symptoms of rhinosinusitis in conscripts at the military induction board
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess the prevalence of rhinosinusitis in conscripts with previous ENT-surgeries
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess differences in symptoms in rhinosinusitis in conscripts with previous ENT-surgeries
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess the combined prevalence of rhinosinusitis and chronic pulmonary diseases in conscripts
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To assess the difference in prevalence of subjective symptoms of rhinosinusitis compared to objective (apparatus based and laboratory based) symptoms of rhinosinusitis
Time frame: Through data collection, an average of 1 week
Prevalence of rhinosinusitis
To analyse demographic data in conscripts with rhinosinusitis
Time frame: Through data collection, an average of 1 week
Prevalence of human papilloma virus vaccines
To assess the prevalence of HPV vaccines among conscripts at the military induction board
Time frame: Through data collection, an average of 1 week
Prevalence of human papilloma virus vaccines
To assess knowledge about HPV and HPV vaccinations and in dependent of that prevalence of HPV vaccines among conscripts at the military induction board
Time frame: Through data collection, an average of 1 week
Prevalence of hearing impairment
To assess the prevalence of hearing impairment in conscripts at the military induction board
Time frame: Through data collection, an average of 1 week
Prevalence of hearing impairment
To assess the difference in prevalence of subjective symptoms of hearing impairment compared to objective (apparatus based and laboratory based) signs of hearing impairment
Time frame: Through data collection, an average of 1 week
Prevalence of hearing impairment
To analyse demographic data in conscripts with hearing impairment
Time frame: Through data collection, an average of 1 week
Prevalence of long-COVID
To assess the prevalence of long-COVID in conscripts at the military induction board
Time frame: Through data collection, an average of 1 week
Prevalence of long-COVID
To assess different symptoms of long-COVID in conscripts at the military induction board
Time frame: Through data collection, an average of 1 week
Prevalence of COVID-19 infection
To assess the prevalence of previous COVID 19 infections in conscripts at the military induction board
Time frame: Through data collection, an average of 1 week
Prevalence of long-COVID
To analyse demographic data in conscripts with long-COVID
Time frame: Through data collection, an average of 1 week
No study locations are listed for this record.
Start is estimated for Dec 2023; primary completion for Dec 2025, 24 months later.
Of 22 observational studies under Rhinosinusitis, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 71. This study's planned 24 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.